Clinical trial
Clinical Evaluation of a New Reduced Volume Bowel Preparation
NCT00321230 · Norgine, Industry · Completed
Key facts
| NCT number | NCT00321230 |
|---|---|
| Title | Clinical Evaluation of a New Reduced Volume Bowel Preparation |
| Official title | A Pilot Monocentric, Open Phase II Study to Investigate the Efficacy and Safety of a New Oral Gut Cleansing Solution ("Low Dose Bowel Prep") in 30 Patients Submitted to Colonoscopy |
| Lead sponsor | Norgine, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colonoscopy |
| Intervention type | Drug |
| Interventions | macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate |
| Enrollment | 30 |
| Start date | Jan 1, 2001 |
| Completion | May 1, 2001 |
| First posted | May 3, 2006 |
| Last update posted | Apr 16, 2008 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: